Literature DB >> 9824868

Accidental subretinal injection of triamcinolone acetonide.

M Modarres1, M M Parvaresh, G A Peyman.   

Abstract

Approximately one-third of the contents of a 1-ml, 40-mg ampule of triamcinolone acetonide was accidentally injected into the subretinal space of the left eye of a 30-year-old man with chronic uveitis. The manufacturer provided a list of the contents of the ampule. A large, white subretinal mass was seen in the superotemporal quadrant. In subsequent days, the medication was seen to migrate inferiorly. Visual acuity in the left eye was 20/400. Subretinal hemorrhage and mild atrophy of the retinal pigment epithelium and choroid were observed superotemporally. Visual acuity returned to 20/100 (preinjection level) in 1 week. Four months postinjection, the superotemporal atrophy was more severe; the inferotemporal medication was minimally visible without producing significant chorioretinal atrophy. The visual acuity remained at 20/100 until the patient underwent cataract extraction and intraocular lens implantation; his vision then improved to 20/40. Steroids, when not accompanied by harmful vehicle substances, may be well tolerated by ocular tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824868

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  8 in total

Review 1.  [Ocular side effects and complications of intravitreal triamcinolone acetonide injection].

Authors:  G B Jaissle; P Szurman; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

2.  Macular atrophy after combined intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.

Authors:  José M Ruiz-Moreno; Javier A Montero; Pedro Amat; Francisco Lugo
Journal:  Int J Ophthalmol       Date:  2010-06-18       Impact factor: 1.779

3.  Cell viability effects of triamcinolone acetonide and preservative vehicle formulations.

Authors:  S Shaikh; S Ho; L A Engelmann; S W Klemann
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

4.  [Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling].

Authors:  G B Jaissle; K U Bartz-Schmidt; P Szurman
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

5.  Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis.

Authors:  A A Okada; T Wakabayashi; Y Morimura; S Kawahara; E Kojima; Y Asano; T Hida
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

6.  Natural history of sub-retinal triamcinolone acetonide deposition after triamcinolone-assisted vitrectomy.

Authors:  Raju Sampangi; Pradeep Venkatesh; Sat Pal Garg
Journal:  Int Ophthalmol       Date:  2007-09-26       Impact factor: 2.031

7.  Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study.

Authors:  Maurício Maia; Fernando Marcondes Penha; Michel Eid Farah; Eduardo Dib; André Príncipe; Acácio A S Lima Filho; Octaviano Magalhães; Edna Freymüller; Eduardo B Rodrigues
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-12-11       Impact factor: 3.117

Review 8.  [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors:  J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.